S
Sotirios G. Papageorgiou
Researcher at National and Kapodistrian University of Athens
Publications - 136
Citations - 2135
Sotirios G. Papageorgiou is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 21, co-authored 112 publications receiving 1755 citations. Previous affiliations of Sotirios G. Papageorgiou include Athens State University.
Papers
More filters
Journal ArticleDOI
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias
Flora Tzifi,Christina Economopoulou,Dimitrios Gourgiotis,Alexandros Ardavanis,Sotirios G. Papageorgiou,Andreas Scorilas +5 more
TL;DR: Current knowledge on the role of BCL2 apoptosis regulator proteins in acute and chronic leukemias is described to lead to the design of new therapies which may improve patients' survival.
Journal ArticleDOI
The role of microRNAs in normal and malignant hematopoiesis.
Diamantina Vasilatou,Sotirios G. Papageorgiou,Vassiliki Pappa,Efstathios Papageorgiou,John Dervenoulas +4 more
TL;DR: The purpose of this review is to summarize current knowledge on the role of microRNAs in normal hematopoiesis and hematoietic malignancies and to highlight their role as potential therapeutic tools.
Journal ArticleDOI
Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management.
TL;DR: Various therapeutic aspects for primary gastric lymphomas are still controversial and several questions remain unanswered, among others, the role of rituximab, consolidation radiotherapy as well as H. pylori eradication in histological aggressive subtypes warrants better clarification.
Journal ArticleDOI
Primary gastrointestinal non-Hodgkin's lymphoma : A clinicopathologic study of 128 cases in Greece. A hellenic Cooperative Oncology Group study (HeCOG)
George Papaxoinis,Sotirios G. Papageorgiou,Dimitra Rontogianni,Vassiliki Kaloutsi,George Fountzilas,N. Pavlidis,Meletios A. Dimopoulos,Constantinos Tsatalas,Nikolaos Xiros,Theofanis Economopoulos +9 more
TL;DR: The aim of this retrospective study was to illustrate the clinicopathologic data and the treatment results in patients with primary gastrointestinal tract non-Hodgkin's lymphoma (GI NHL).
Journal ArticleDOI
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.
Theodoros P. Vassilakopoulos,Gerassimos A. Pangalis,Andreas Katsigiannis,Sotirios G. Papageorgiou,Nikos Constantinou,Evangelos Terpos,Alexandra Zorbala,Effimia Vrakidou,Panagiotis Repoussis,Christos Poziopoulos,Zacharoula Galani,Maria N. Dimopoulou,Stella I. Kokoris,Sotirios Sachanas,Christina Kalpadakis,Evagelia M. Dimitriadou,Marina P. Siakantaris,Marie-Christine Kyrtsonis,John Dervenoulas,Meletios A. Dimopoulos,John Meletis,Paraskevi Roussou,Panayiotis Panayiotidis,Photis Beris,Maria K. Angelopoulou +24 more
TL;DR: Most patients with PMLBCL appear to be cured by R-CHOP in 21-day cycles with or without RT, which could be the current standard of care, and the need for more aggressive treatment strategies is questionable unless high-risk patients are adequately defined.